Home >> News >> News >> Content

Glance of the IASLC WCLC 2017

November 13, 2017 Mi Gan []

6364581500973437506067115.jpg

Recently, Dr. Tao Li of SCH attended the the IASLC WCLC 2017 in yokohama, Japan. As the largest conference on lung cancer of the world, the conference got attention of nearly 10000 audients from more than 100 countries, which is the biggest academic event of worldwide communication. Radiotherapy becomes the main treatment of lung cancer, and individualized treatment has been developed a lot though the exercise on lung cancer.

NSCLC Stage I: SBRT is the priority treatment

There was a seminar on Best Practice for Small-sized Early Stage Lung Cancer: Standard Surgery, Limited Resection, SBRT, focus on NSCLC Stage I treatment. Joe Chang from MD Anderson Cancer Center shared his experience on SBRT.

NSCLC IIIA(N2): Radiotherapy is the standard treatment

NSCLC metastasis: Radiotherapy on primary lesion as early as possible

NSCLC advanced: Radiotherapy is the most effective and economic palliative treatment

NSCLC treatment in future: Radioactive immunotherapy and target combination therapy

Contact us

+86-028-85420243    +86-028-85420305

Phone

Subscription number

Official Weibo

Copyright © 2020 Sichuan Cancer Hospital   Hospital address: No.55,Section 4,South Renmin Road,Chengdu,China  Medical care information release   技术支持:博达软件